Tech Company Inital Public Offerings
Rosetta Genomics IPO
Based in Rehovot, Rosetta Genomics completed its IPO.
Transaction Overview
Company Name
Announced On
2/27/2007
Transaction Type
IPO
Amount
$26,250,000
Proceeds Purpose
Proceeds purposes are detailed in the company's SEC filing statements.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
10 Plaut St.
Rehovot, 76706
Israel
Rehovot, 76706
Israel
Phone
Website
Email Address
Overview
Rosetta Genomics (Nasdaq: ROSG) is an international leader in diagnostic and therapeutic product development and medical research involving micro-ribonucleic acid, commonly known as microRNA.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Brian Markison
Chief Executive Officer
Kenneth Berlin
Chief Financial Officer
Ron Kalfus
Chief Scientific Officer
Dganit Bar
VP - General Counsel
Oded Biran
Browse more venture capital transactions:
Prev: 2/27/2007: MATE Intelligent Video venture capital transaction
Next: 2/28/2007: Impulse Monitoring venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs